Whether it is over mixing bowls, the stove or the kitchen table, so many memories are created in the kitchen. Cooking brings people together. Elise Bauer, creator of Simply Recipes knows this, and has dedicated her site to tasty, high-quality recipes using ingredients you probably already have in your kitchen.
One of Elise’s favorite ingredients is California Ripe Olives; the unique flavor profile lends itself well to so many dishes from breakfast to dessert and everything in between.
To view the multimedia release go to:
https://www.multivu.com/players/English/8268151-california-ripe-olives-simple-recipes-elise-bauer/
Phenogen Sciences, Inc. today announced the availability of BREVAGenplus, an easy-to-use predictive risk test for the millions of women at risk of developing sporadic, or non-hereditary, breast cancer. The test is an enhancement of the company’s first generation product, BREVAGen®. BREVAGenplus assesses both clinical risk factors and genetic markers known to be associated with sporadic, or non-hereditary, breast cancer to determine a woman’s five-year and lifetime risk of developing the disease. The test is designed to facilitate better informed decisions about breast cancer screening and preventive treatment plans for Caucasian, Hispanic and African-American women, age 35 years or above, who have not had breast cancer, lobular carcinoma in situ (LCIS) or ductal carcinoma in situ (DCIS), and have one or more risk factors for developing breast cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7337351-phenogen-sciences-introduces-brevagenplus-breast-cancer-risk-assessment-test/
Following FDA approval of the AspireSR® generator for the VNS Therapy® system in June 2015, more than a thousand patients with drug-resistant epilepsy across the United States have received this new treatment option. Many of these patients are experiencing benefits which have positively impacted their lives – and are sharing their stories during Epilepsy Awareness Month with the hope of encouraging others to seek new treatments for drug-resistant epilepsy. Numerous hospitals nationwide have begun providing the AspireSR device to patients with drug-resistant epilepsy – a condition that affects as many as one-third of people with epilepsy, causing them to have seizures in spite of treatment with antiepileptic medications.
The VNS Therapy system is a minimally invasive option in which a medical device is placed under the skin in the upper chest area during an outpatient procedure. The device sends mild electrical pulses through the vagus nerve to areas of the brain known to be associated with seizures. The new AspireSR generator takes the VNS Therapy technology a step further – detecting relative heart-rate increases that are often associated with seizures in people with epilepsy and providing responsive stimulation in an attempt to stop and shorten seizures and improve recovery.
To view the multimedia release go to:
http://www.multivu.com/players/English/7651751-livanova-aspiresr-treatment/
It’s no surprise that being a new mom can be challenging. Your time and energy are put towards hectic schedules, escalating costs of raising an infant and making sure you’re caring for your little one properly. Maintaining healthy habits for both mommy and baby is essential once your little one has arrived as well. Dr. Peterson shares her health tips for both pregnant mommies and newborn babies.
To view the multimedia release go to:
https://www.multivu.com/players/English/82267241-tips-for-new-moms-babies/
George Freeman MP, the Minister for Life Sciences, will give the keynote address at the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
Organised and funded by Astellas, a progressive pharmaceutical company that explores the frontiers of scientific discovery to translate new knowledge into innovative, reliable medicines, the Astellas Innovation Debates are a series of annual events that bring together some of the world’s most progressive thinkers to discuss the role of innovation in solving some of the greatest challenges of our time.
George Freeman’s keynote address will outline the Government’s aim to develop, assess and adopt new drugs, devices and diagnostics as we move towards 21st century, personalised healthcare.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7423951-george-freeman-astellas-debate/
Technology leader Samsung Electronics Co. Ltd., together with global health service company Cigna, today announced a new version of the Coach by Cigna mobile application that features the psychology of lateral assessment to identify your personality type, understands your wants, needs and preferences, and provides the right programs to help with diet, exercise, sleep, stress and weight.
Coach by Cigna is available at no charge in the Google Play store for Samsung Galaxy S6, S6 Edge, Galaxy S5, Galaxy Note 4 and Note Edge mobile devices.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7448831-coach-by-cigna-fitness-app/
Zelda was found filthy, hungry and matted. Barely recognizable as a dog, her rescuers cleaned her up to reveal a tiny Shih Tzu. Unfortunately, Zelda’s story is similar to the nearly 8 million other animals entering shelters each year. That’s why Wahl has teamed up with GreaterGood.org to donate funds and grooming supplies to shelters nationwide. The goal: Transform more than 20,000 dogs this year and get them ready for adoption.
“Due to lack of resources, less than half of dogs entering shelters are getting the grooming they desperately need,” says Shay Moeller, pet product manager for Wahl. “First impressions are crucial, and without proper grooming, many of these dogs are perceived to be ‘damaged goods.’ By providing shelters with much-needed grooming supplies, we can transform these dogs into the healthy, fun loving pets they really are.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7828751-wahl-dirty-dogs-contest/
A Firefly is lighting up operating rooms, making it easier for robotic surgeons to remove tumors. However, this Firefly is not the type that children catch in a jar during warm summer evenings. Instead, it’s a technology that uses a wavelength of light not visible to the human eye. A special dye is then injected which causes a bright green fluorescence of certain tissues, hence the name “Firefly.” This green glow lets surgeons clearly see the difference between cancerous and healthy tissue when performing surgery, allowing them to remove the tumor while saving the rest of the healthy organ.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7342452-firefly-lighting-operating-rooms/
When Amway™ asked for help in raising awareness about global childhood malnutrition through its Nutrilite™ Power of 5 Campaign, more than 260,000 people across the globe raised their hand to do just that. And they broke a GUINNESS WORLD RECORDS™ title in the process.
As a global leader in nutrition research, development and innovation, Amway paired its expertise from Nutrilite™, the world’s number one selling vitamins and dietary supplements brand*, with its passion for helping people live better lives. Amway™ last year launched the Nutrilite™ Power of 5 Campaign to expand the distribution of the Nutrilite™ Little Bits™ supplement. At the time, the micronutrient powder with 15 essential vitamins and minerals for children was being distributed in two countries through established programs run by Non-Governmental Organizations. It has since expanded to nine countries and there are plans for more.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7214653-amway-guinness-world-record/
FDA’s Read the Label Youth Outreach Campaign is an exciting initiative that challenges kids (ages 9 to 13) to “get their food facts first” by using the Nutrition Facts Label to make healthy food choices. Read the Label campaign materials enable parents and caregivers to help kids use this important tool.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7106352-fda-read-the-label-youth-outreach-campaign-tweens-healthy-choices
ACCU-CHEK Aviva Expert offers people with diabetes a new and easy way to simplify complex calculations to deliver precise insulin dosing advice.
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the ACCU-CHEK® Aviva Expert system, the first and only blood glucose meter system with a built-in insulin calculator to be approved by the U.S. Food and Drug Administration (FDA), is now available by prescription. The device represents a significant advancement in blood glucose meter technology for people with diabetes who take multiple daily insulin injections. The meter’s integrated bolus calculator provides easy-to-use and reliable dose recommendations based on automated calculations, eliminating the need for manual dosing calculations and estimations.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322751-roche-accu-chek-aviva-expert-blood-glucose-meter-now-available/
If the world warms by two degrees, some of the changes to the biosphere are no longer gradual.
Six Degrees Could Change the World
Sunday, February 10 8 PM et/ 9 PM pt
http:/channel.nationalgeographic.com/channel/sixdegrees/?source=4003
